ABCA6

gene
On this page

Also known as EST155051

Summary

ABCA6 (ATP binding cassette subfamily A member 6, HGNC:36) is a protein-coding gene on chromosome 17q24.2-q24.3, encoding ATP-binding cassette sub-family A member 6 (Q8N139). Probable transporter which may play a role in macrophage lipid transport and homeostasis.

The membrane-associated protein encoded by this gene is a member of the superfamily of ATP-binding cassette (ABC) transporters. ABC proteins transport various molecules across extra- and intracellular membranes. ABC genes are divided into seven distinct subfamilies (ABC1, MDR/TAP, MRP, ALD, OABP, GCN20, and White). This encoded protein is a member of the ABC1 subfamily. Members of the ABC1 subfamily comprise the only major ABC subfamily found exclusively in multicellular eukaryotes. This gene is clustered among 4 other ABC1 family members on 17q24 and may play a role in macrophage lipid homeostasis.

Source: NCBI Gene 23460 — RefSeq curated summary.

At a glance

  • GWAS associations: 47
  • Clinical variants (ClinVar): 256 total — 1 pathogenic
  • MANE Select transcript: NM_080284

Identifiers

Gene identifiers

FieldValue
HGNC IDHGNC:36
Approved symbolABCA6
NameATP binding cassette subfamily A member 6
Location17q24.2-q24.3
Locus typegene with protein product
StatusApproved
AliasesEST155051
Ensembl geneENSG00000154262
Ensembl biotypeprotein_coding
OMIM612504
Entrez23460

Gene structure

Transcript identifiers

Ensembl transcripts: 18 — 13 protein_coding, 3 retained_intron, 2 protein_coding_CDS_not_defined

ENST00000284425, ENST00000446604, ENST00000589482, ENST00000589803, ENST00000590311, ENST00000590645, ENST00000592493, ENST00000886834, ENST00000886835, ENST00000886836, ENST00000886837, ENST00000886838, ENST00000886839, ENST00000886840, ENST00000886841, ENST00000886842, ENST00000886843, ENST00000886844

RefSeq mRNA: 1 — MANE Select: NM_080284 NM_080284

CCDS: CCDS11683

Canonical transcript exons

ENST00000284425 — 39 exons

ExonStartEnd
ENSE000011049336913609269136250
ENSE000011049486913729669137500
ENSE000011049756912323969123407
ENSE000011049996912861969128804
ENSE000011050046912488869125035
ENSE000011050076913364169133867
ENSE000011050096913463969134742
ENSE000011488636914060869140748
ENSE000011874036914174569141895
ENSE000022092826907870269079074
ENSE000022679676910079769100934
ENSE000022702246910283569102968
ENSE000023219696910546269105628
ENSE000024442366911789869117956
ENSE000025039986912961069129751
ENSE000034606246911476269114937
ENSE000034617316910769669107812
ENSE000034618816908443269084507
ENSE000034685976909114369091262
ENSE000034911916908321269083331
ENSE000035119116908661869086735
ENSE000035373716911218369112273
ENSE000035455396908816769088258
ENSE000035554656908562569085716
ENSE000035927326911537669115486
ENSE000035953726909792069098027
ENSE000036212926911361869113737
ENSE000036226546911322269113360
ENSE000036288846908502869085182
ENSE000036522986907921069079265
ENSE000036533796908106669081145
ENSE000036562566910602869106211
ENSE000036628706908946569089542
ENSE000036709696908287369083013
ENSE000036756006909662869096801
ENSE000036778306909624069096353
ENSE000036824786908735369087473
ENSE000036878896908426169084355
ENSE000036927786911080169110940

Expression profiles

Bgee: expression breadth ubiquitous, 206 present calls, max score 96.94.

FANTOM5 (CAGE): breadth broad, TPM avg 3.6611 / max 325.6449, expressed in 558 samples.

FANTOM5 promoters (8 alternative TSS)

Promoter IDTPM avgSamples expressed
1677812.7177500
1677820.3782184
1677800.2374106
1677740.138826
1677750.066521
1677790.056826
1677730.03606
1677830.029711

Top tissues by expression

270 total, by Bgee expression score (0-100, higher = more expressed):

TissueAnatomy IDExpression scoreQuality
calcaneal tendonUBERON:000370196.94gold quality
tibial nerveUBERON:000132396.13gold quality
mucosa of stomachUBERON:000119996.10gold quality
sural nerveUBERON:001548895.20gold quality
right lungUBERON:000216795.17gold quality
left ovaryUBERON:000211994.88gold quality
right lobe of liverUBERON:000111494.78gold quality
subcutaneous adipose tissueUBERON:000219094.06gold quality
right ovaryUBERON:000211893.23gold quality
omental fat padUBERON:001041492.95gold quality
peritoneumUBERON:000235892.81gold quality
apex of heartUBERON:000209892.77gold quality
right atrium auricular regionUBERON:000663192.77gold quality
liverUBERON:000210792.48gold quality
adipose tissue of abdominal regionUBERON:000780892.28gold quality
cardiac atriumUBERON:000208191.52gold quality
adipose tissueUBERON:000101390.37gold quality
esophagogastric junction muscularis propriaUBERON:003584190.27gold quality
right coronary arteryUBERON:000162589.75gold quality
lower esophagus muscularis layerUBERON:003583389.63gold quality
lower esophagusUBERON:001347389.59gold quality
left coronary arteryUBERON:000162689.35gold quality
connective tissueUBERON:000238489.30gold quality
tendonUBERON:000004388.68gold quality
minor salivary glandUBERON:000183088.56gold quality
coronary arteryUBERON:000162188.17gold quality
endocervixUBERON:000045888.12gold quality
colonic epitheliumUBERON:000039787.98gold quality
heartUBERON:000094887.68gold quality
heart left ventricleUBERON:000208487.60gold quality

Single-cell (SCXA)

Detected in 4 experiment(s), a significant marker in 4.

ExperimentMarker?Max mean expression
E-ANND-2yes3292.26
E-MTAB-11268yes1444.49
E-GEOD-180759yes982.61
E-ANND-3no0.00

Regulation

Is transcription factor: no

miRNA regulators (miRDB)

18 targeting ABCA6, top 30 by miRDB confidence (max_score; target_count = how many genes the miRNA targets in total — lower means more specific):

miRNAMax scoreAvg scoremiRNA target_count
HSA-MIR-3924100.0072.092394
HSA-MIR-3613-3P100.0076.367965
HSA-MIR-428299.9975.366408
HSA-MIR-477599.9875.006394
HSA-MIR-3692-3P99.9870.272139
HSA-MIR-3065-5P99.9771.563281
HSA-MIR-590-3P99.9674.346478
HSA-MIR-94499.8270.853042
HSA-MIR-7159-5P99.5372.122472
HSA-MIR-6507-5P99.3670.462524
HSA-MIR-10522-5P99.2668.502087
HSA-MIR-126298.1766.52757
HSA-MIR-4701-3P98.1766.25788
HSA-MIR-6736-5P98.1766.43760
HSA-MIR-3144-3P98.1567.34677
HSA-MIR-6802-3P97.2965.42613
HSA-MIR-6888-5P95.8963.78831
HSA-MIR-468395.2965.98631

Literature-anchored findings (GeneRIF, showing 6)

  • These data provide evidence for an essential role of FoxO proteins in the transcription of ABCA6 in human vascular endothelial cells. (PMID:24028821)
  • Results suggest a possible role for multidrug resistance genes ABCA10 and ABCA6 in follicular lymphoma survival and add to the evidence that genetic variation in CD46 and IL8 may have prognostic implications follicular lymphoma. (PMID:25294155)
  • A rare missense variant in ABCA6 (rs77542162, p.Cys1359Arg, frequency 0.034), found in a Dutch population, is predicted to be deleterious with respect to blood cholesterol levels. (PMID:25751400)
  • The Evolution of the Mammalian ABCA6-like Genes: Analysis of Phylogenetic, Expression, and Population Genetic Data Reveals Complex Evolutionary Histories. (PMID:32877505)
  • Hypercholesterolemia risk associated Abca6 does not regulate lipoprotein metabolism in mice or hamster. (PMID:34274505)
  • ABCA6 affects the malignancy of Ewing sarcoma cells via cholesterol-guided inhibition of the IGF1R/AKT/MDM2 axis. (PMID:36149602)

Cross-species orthologs

16 orthologs

OrganismSymbolGene ID
danio_rerioabca5ENSDARG00000074041
mus_musculusAbca6ENSMUSG00000044749
rattus_norvegicusAbca6ENSRNOG00000046890
drosophila_melanogasterEatoFBGN0028539
drosophila_melanogasterCG1494FBGN0031169
drosophila_melanogasterAbca3FBGN0031170
drosophila_melanogasterCG1801FBGN0031171
drosophila_melanogasterCG8908FBGN0034493
drosophila_melanogasterCG6052FBGN0036747
drosophila_melanogasterCG31213FBGN0051213
drosophila_melanogasterlddFBGN0083956
drosophila_melanogasterCG43672FBGN0263747
caenorhabditis_elegansWBGENE00000019
caenorhabditis_elegansabt-2WBGENE00000020
caenorhabditis_elegansWBGENE00000022
caenorhabditis_elegansabt-5WBGENE00000023

Paralogs (11): ABCA7 (ENSG00000064687), ABCA2 (ENSG00000107331), ABCA8 (ENSG00000141338), ABCA12 (ENSG00000144452), ABCA9 (ENSG00000154258), ABCA10 (ENSG00000154263), ABCA5 (ENSG00000154265), ABCA1 (ENSG00000165029), ABCA3 (ENSG00000167972), ABCA13 (ENSG00000179869), ABCA4 (ENSG00000198691)

Protein

Protein identifiers

ATP-binding cassette sub-family A member 6Q8N139 (reviewed: Q8N139)

All UniProt accessions (1): Q8N139

UniProt curated annotations — full annotation on UniProt →

Function. Probable transporter which may play a role in macrophage lipid transport and homeostasis.

Subcellular location. Golgi apparatus membrane.

Tissue specificity. Widely expressed with higher expression in liver.

Induction. Up-regulated during monocyte differentiation into macrophages. Down-regulated by cholesterol loading of macrophages.

Similarity. Belongs to the ABC transporter superfamily. ABCA family.

Isoforms (3)

UniProt IDNamesCanonical?
Q8N139-11yes
Q8N139-22, ABCA6delta-139
Q8N139-33

RefSeq proteins (1): NP_525023* (*=MANE)

Domains & families (InterPro)

IDNameType
IPR003439ABC_transporter-like_ATP-bdDomain
IPR003593AAA+_ATPaseDomain
IPR013525ABC2_TMDomain
IPR026082ABCAFamily
IPR027417P-loop_NTPaseHomologous_superfamily
IPR056264R2_ABCA1-4-likeDomain

Pfam: PF00005, PF12698, PF23321

UniProt features (35 total): transmembrane region 14, sequence variant 5, splice variant 4, sequence conflict 4, glycosylation site 3, domain 2, binding site 2, chain 1

Structure

Experimental structures (PDB)

0 structures.

Predicted structure (AlphaFold)

ModelpLDDTFraction very-high
AF-Q8N139-F177.380.13

Functional residue map

Curated UniProt residues grouped by drug-discovery relevance — catalytic, ligand-binding, modification, and mutation-validated positions. Source: UniProtKB sequence features.

Ligand- & substrate-binding residues (2): 514–521; 1320–1327

Glycosylation sites (3): 84, 109, 940

Function

Pathways and Gene Ontology

Reactome pathways

8 pathways

IDPathway
R-HSA-1369062ABC transporters in lipid homeostasis
R-HSA-9615017FOXO-mediated transcription of oxidative stress, metabolic and neuronal genes
R-HSA-212436Generic Transcription Pathway
R-HSA-382551Transport of small molecules
R-HSA-382556ABC-family protein mediated transport
R-HSA-73857RNA Polymerase II Transcription
R-HSA-74160Gene expression (Transcription)
R-HSA-9614085FOXO-mediated transcription

MSigDB gene sets: 111 (showing top): GSE45365_NK_CELL_VS_CD8_TCELL_UP, BROWNE_HCMV_INFECTION_8HR_UP, CEBPB_01, KEGG_ABC_TRANSPORTERS, BROWNE_HCMV_INFECTION_48HR_DN, CAIRO_HEPATOBLASTOMA_CLASSES_DN, HFH4_01, CORRE_MULTIPLE_MYELOMA_UP, BERTUCCI_INVASIVE_CARCINOMA_DUCTAL_VS_LOBULAR_DN, GOBP_LIPID_LOCALIZATION, NIKOLSKY_BREAST_CANCER_17Q21_Q25_AMPLICON, GOBP_TRANSMEMBRANE_TRANSPORT, CHIANG_LIVER_CANCER_SUBCLASS_PROLIFERATION_DN, PAX2_02, GOMF_LIPID_TRANSPORTER_ACTIVITY

GO Biological Process (2): lipid transport (GO:0006869), transmembrane transport (GO:0055085)

GO Molecular Function (6): lipid carrier activity (GO:0005319), ATP binding (GO:0005524), ATP hydrolysis activity (GO:0016887), ATPase-coupled transmembrane transporter activity (GO:0042626), ABC-type transporter activity (GO:0140359), nucleotide binding (GO:0000166)

GO Cellular Component (5): Golgi membrane (GO:0000139), nucleoplasm (GO:0005654), plasma membrane (GO:0005886), Golgi apparatus (GO:0005794), membrane (GO:0016020)

Reactome top-level categories

Rollup of top-6 pathways:

CategoryPathways
ABC-family protein mediated transport1
FOXO-mediated transcription1
RNA Polymerase II Transcription1
Transport of small molecules1
Gene expression (Transcription)1
Generic Transcription Pathway1

GO top-level categories

Rollup of top GO terms by namespace:

CategoryTerms
transport2
ATP-dependent activity2
cellular anatomical structure2
lipid localization1
cellular process1
molecular carrier activity1
adenyl ribonucleotide binding1
purine ribonucleoside triphosphate binding1
ribonucleoside triphosphate phosphatase activity1
primary active transmembrane transporter activity1
ATP hydrolysis activity1
ATPase-coupled transmembrane transporter activity1
nucleoside phosphate binding1
heterocyclic compound binding1
Golgi apparatus1
bounding membrane of organelle1
nuclear lumen1
membrane1
cell periphery1
cytoplasm1
endomembrane system1
intracellular membrane-bounded organelle1

Protein interactions and networks

STRING

1004 interactions, top by confidence (×1000):

Protein AProtein BPartner UniProtScore
ABCA6MAP2K6P52564594
ABCA6SLC22A8Q8TCC7511
ABCA6ABCF3Q9NUQ8462
ABCA6ABCC3O15438444
ABCA6APODP05090416
ABCA6ABCD4O14678407
ABCA6ABCA12Q86UK0395
ABCA6SLC27A6Q9Y2P4394
ABCA6ABCA8O94911389
ABCA6MSLNLQ96KJ4387
ABCA6SLCO1B1Q9Y6L6376
ABCA6MRASO14807362
ABCA6SARM1Q6SZW1353
ABCA6ABCF1Q8NE71346
ABCA6ABCB1P08183343

IntAct

3 interactions, top by confidence:

ABTypeScore
APOA1CNMDpsi-mi:“MI:0914”(association)0.350
ABCA6STX6psi-mi:“MI:0914”(association)0.350

BioGRID (16): ABCA10 (Affinity Capture-MS), DNAJC30 (Affinity Capture-MS), ABCA8 (Affinity Capture-MS), STX6 (Affinity Capture-MS), FADS1 (Affinity Capture-MS), ANKLE2 (Affinity Capture-MS), CISD3 (Affinity Capture-MS), ABCA2 (Affinity Capture-MS), ABCA6 (Affinity Capture-MS), ABCA6 (Proximity Label-MS), ABCA6 (Proximity Label-MS), ABCA6 (Proximity Label-MS), ABCA6 (Proximity Label-MS), ABCA6 (Proximity Label-MS), ABCA6 (Proximity Label-MS)

ESM2 similar proteins: A0A0G2K1Q8, B2RX12, E9PU17, E9PX95, F1MWM0, O00329, O15438, O35600, O75899, O88563, O88871, O94911, O95477, P41233, P55205, P58428, P78363, Q09427, Q09428, Q09429, Q2NKY8, Q5BJS0, Q5R607, Q5ZI74, Q6TL19, Q7L2E3, Q7TNJ2, Q80T41, Q84M24, Q8CF82, Q8IUA7, Q8K440, Q8K441, Q8K442, Q8K448, Q8K449, Q8LPK0, Q8N139, Q8NCL4, Q8R420

Diamond homologs: A0A059J0G5, A0A0M3R8G1, A0A1L9WQK0, A0A1U8QKX8, A0A1U8QT10, A0A1V0QSE4, A0A1V1GB10, A0A1Y0BRF0, A0A2H1A768, A0A2U8U2K9, A0A481WQK1, A0A4P8GG95, A0A8K1AW53, A1C8C8, A1CFM0, A9YWR6, B6HV31, B6RAL1, B8NDS8, B9G5Y5, D3GE74, D4AYW0, E9RBG1, F2PLH2, F2RSQ6, F2SG60, F2SHL1, G3JF11, I1RL06, J9VME1, J9VPA2, M2UCE5, O42690, O65934, O74208, O74676, P32568, P33302, P40550, P41820

SIGNOR signaling

0 interactions.

Disease & clinical

Clinical variants and AI predictions

ClinVar

256 variants total. Per-class counts are floors (≥ shown; pagination cap):

ClassificationCount (floor)
Pathogenic1
Likely pathogenic0
Uncertain significance207
Likely benign25
Benign0

Top pathogenic / likely-pathogenic (1)

Variant IDHGVSClassification
685257GRCh37/hg19 17q23.1-24.2(chr17:57869604-67078443)x3Pathogenic

SpliceAI

5892 predictions. Top by Δscore:

VariantEffectΔscore
17:69079208:A:ACdonor_gain1.0000
17:69079209:C:CAdonor_loss1.0000
17:69079209:C:CCdonor_gain1.0000
17:69079209:CCTT:Cdonor_gain1.0000
17:69079261:CTTCA:Cacceptor_gain1.0000
17:69079262:TTCA:Tacceptor_gain1.0000
17:69079263:TCA:Tacceptor_gain1.0000
17:69079264:CA:Cacceptor_gain1.0000
17:69079264:CAC:Cacceptor_gain1.0000
17:69079265:AC:Aacceptor_loss1.0000
17:69079266:C:CCacceptor_gain1.0000
17:69082867:TCTCA:Tdonor_loss1.0000
17:69082868:CTCA:Cdonor_loss1.0000
17:69082869:TCAC:Tdonor_loss1.0000
17:69082870:CAC:Cdonor_loss1.0000
17:69082871:A:Tdonor_loss1.0000
17:69082872:CCTT:Cdonor_loss1.0000
17:69082876:T:Adonor_gain1.0000
17:69083011:CAT:Cacceptor_gain1.0000
17:69083012:ATC:Aacceptor_loss1.0000
17:69083013:TCTAT:Tacceptor_loss1.0000
17:69083014:C:CCacceptor_gain1.0000
17:69083014:CT:Cacceptor_loss1.0000
17:69083015:T:Cacceptor_loss1.0000
17:69083214:AAG:Adonor_gain1.0000
17:69084353:CAA:Cacceptor_gain1.0000
17:69084356:C:CCacceptor_gain1.0000
17:69084427:CGTA:Cdonor_loss1.0000
17:69084428:GTAC:Gdonor_loss1.0000
17:69084429:TACC:Tdonor_loss1.0000

AlphaMissense

10715 scored. Top likely-pathogenic:

VariantProtein changeam_pathogenicity
17:69128649:G:CS363R0.986
17:69128649:G:TS363R0.986
17:69128651:T:GS363R0.986
17:69102861:C:GA950P0.981
17:69100863:G:CS982R0.977
17:69100863:G:TS982R0.977
17:69100865:T:GS982R0.977
17:69100890:A:CC973W0.976
17:69100911:A:CC966W0.966
17:69100913:A:GC966R0.964
17:69113652:A:GL623P0.963
17:69112186:A:GL710P0.961
17:69113256:A:CS669R0.959
17:69113256:A:TS669R0.959
17:69113258:T:GS669R0.959
17:69084338:G:CS1426R0.958
17:69084338:G:TS1426R0.958
17:69084340:T:GS1426R0.958
17:69100892:A:GC973R0.958
17:69086626:A:TV1310D0.957
17:69083242:C:GR1482P0.956
17:69114814:A:GL577P0.956
17:69137362:A:CY79D0.955
17:69134650:C:GA185P0.954
17:69102851:A:TV953D0.953
17:69100923:A:CF962L0.952
17:69100923:A:TF962L0.952
17:69100925:A:GF962L0.952
17:69136165:A:CF129L0.952
17:69136165:A:TF129L0.952

dbSNP variants (sampled 300 via entrez): RS1000121805 (17:69062869 T>C), RS1000199865 (17:69140844 T>A), RS1000283661 (17:69101723 A>C), RS1000311054 (17:69074356 C>T), RS1000312824 (17:69087779 T>C), RS1000344004 (17:69073969 T>A), RS1000377231 (17:69081910 G>GT), RS1000382172 (17:69119956 T>C), RS1000387041 (17:69133320 A>G), RS1000406988 (17:69094924 C>G), RS1000437807 (17:69094752 G>C), RS1000494072 (17:69109131 T>C), RS1000494590 (17:69100273 C>T), RS1000534062 (17:69142563 A>C), RS1000570636 (17:69067660 AGAAAGAAG>A)

Disease associations

OMIM: gene MIM:612504 | disease phenotypes:

GenCC curated gene-disease

Mondo (0):

Orphanet (0):

HPO phenotypes

0 total (0 of 0 shown, HPO-id order):

GWAS associations

47 associations (top):

StudyTraitp-value
GCST002896_42Cholesterol, total2.000000e-13
GCST002898_37LDL cholesterol2.000000e-18
GCST003031_2MGMT methylation in smokers2.000000e-07
GCST004602_298Mean corpuscular volume3.000000e-12
GCST004604_34Hematocrit2.000000e-13
GCST004615_116Hemoglobin concentration2.000000e-16
GCST004630_220Mean corpuscular hemoglobin2.000000e-13
GCST005580_121Intraocular pressure8.000000e-21
GCST006612_74LDL cholesterol4.000000e-52
GCST006614_59Total cholesterol levels2.000000e-33
GCST007931_27Medication use (HMG CoA reductase inhibitors)6.000000e-16
GCST007931_54Medication use (HMG CoA reductase inhibitors)2.000000e-09
GCST008077_21LDL cholesterol levels2.000000e-07
GCST008077_85LDL cholesterol levels2.000000e-06
GCST008078_149LDL cholesterol levels x alcohol consumption (regular vs non-regular drinkers) interaction (2df)9.000000e-33
GCST008078_58LDL cholesterol levels x alcohol consumption (regular vs non-regular drinkers) interaction (2df)6.000000e-32
GCST008079_4LDL cholesterol levels x alcohol consumption (drinkers vs non-drinkers) interaction (2df)3.000000e-33
GCST008079_46LDL cholesterol levels x alcohol consumption (drinkers vs non-drinkers) interaction (2df)5.000000e-32
GCST008086_24LDL cholesterol levels in current drinkers6.000000e-14
GCST008086_36LDL cholesterol levels in current drinkers1.000000e-15
GCST008277_5Corneal hysteresis7.000000e-11
GCST010083_148Hemoglobin levels6.000000e-36
GCST010204_7Low density lipoprotein cholesterol levels2.000000e-98
GCST010241_41Apolipoprotein A1 levels2.000000e-15
GCST010243_170Apolipoprotein B levels1.000000e-60
GCST010245_222LDL cholesterol levels6.000000e-74
GCST011346_34Total cholesterol levels1.000000e-12
GCST011347_55Low density lipoprotein cholesterol levels1.000000e-13
GCST011390_10Corneal resistance factor2.000000e-78
GCST011391_8Corneal hysteresis7.000000e-66

EFO canonical traits (19, from GWAS)

EFO IDTrait name
EFO:0004574total cholesterol measurement
EFO:0004611low density lipoprotein cholesterol measurement
EFO:0006959gene methylation measurement
EFO:0004348hematocrit
EFO:0004509hemoglobin measurement
EFO:0004527mean corpuscular hemoglobin
EFO:0004695intraocular pressure measurement
EFO:0009932HMG CoA reductase inhibitor use measurement
EFO:0004329alcohol drinking
EFO:0010066corneal hysteresis
EFO:0004614apolipoprotein A 1 measurement
EFO:0004615apolipoprotein B measurement
EFO:0010067corneal resistance factor
EFO:0600007fish oil supplement exposure measurement
EFO:0006925lipoprotein A measurement
EFO:0008343sex interaction measurement
EFO:0004980appendicular lean mass
EFO:0009188Red cell distribution width
EFO:0004533alkaline phosphatase measurement

Drugs & pharmacology

Drug and pharmacology data

Is drug target: no

PharmGKB: 1 entry (VIP=true, CPIC=false)

GtoPdb / IUPHAR curated pharmacology

(IUPHAR/BPS Guide to Pharmacology — expert-curated)

Target class: transporter — ABCA subfamily

CTD chemical–gene interactions

33 total (human), top 30 by PubMed support.

ChemicalActions (top 5)PubMed papers
sodium arsenitedecreases expression2
nickel sulfatedecreases expression2
Acetaminophendecreases expression2
Benzo(a)pyrenedecreases expression, increases methylation, affects methylation2
Carbamazepineaffects expression, increases expression2
Valproic Aciddecreases expression, decreases methylation2
Aflatoxin B1decreases expression, decreases methylation2
bisphenol Fincreases expression1
methyleugenoldecreases expression1
propylparabendecreases expression1
lead acetatedecreases expression1
cupric chloridedecreases expression1
perfluorooctane sulfonic aciddecreases expression1
perfluoro-n-nonanoic aciddecreases expression1
2,2’,4,4’,5-brominated diphenyl etherdecreases expression1
bisphenol Sdecreases expression1
incobotulinumtoxinAincreases expression1
Docetaxelincreases expression, decreases response to substance1
Benzalkonium Compoundsdecreases expression1
Cadmiumdecreases expression1
Cisplatinaffects response to substance1
Dexamethasoneincreases expression1
Dinitrochlorobenzenedecreases expression1
Doxorubicindecreases expression1
Eugenoldecreases expression1
Nickeldecreases expression1
Oxazolonedecreases expression1
Phenobarbitalaffects expression1
Progesteroneincreases expression1
Sodium Dodecyl Sulfatedecreases expression1

Clinical trials (associated diseases)

0 trials via MONDO — disease-level, not drug-specific.

No linked Atlas pages yet — the cross-entity mesh grows as the corpus expands.